NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,848,834 | -9.0% | 832,742 | +0.1% | 0.06% | -5.2% |
| Q2 2023 | $40,482,687 | -13.9% | 831,950 | -1.8% | 0.06% | -17.1% |
| Q1 2023 | $47,024,774 | +38.3% | 846,988 | +0.0% | 0.07% | +29.6% |
| Q4 2022 | $34,012,863 | -4.7% | 846,723 | +4.0% | 0.05% | -8.5% |
| Q3 2022 | $35,686,000 | +8.0% | 814,385 | -9.2% | 0.06% | +18.0% |
| Q2 2022 | $33,054,000 | -14.8% | 896,514 | -4.3% | 0.05% | -2.0% |
| Q1 2022 | $38,817,000 | -31.0% | 936,482 | +55.5% | 0.05% | -30.1% |
| Q4 2021 | $56,239,000 | -2.5% | 602,196 | +16.4% | 0.07% | -18.0% |
| Q3 2021 | $57,661,000 | -6.3% | 517,415 | -4.6% | 0.09% | +15.6% |
| Q2 2021 | $61,561,000 | +169.9% | 542,243 | +141.3% | 0.08% | +156.7% |
| Q1 2021 | $22,813,000 | -52.0% | 224,675 | -52.9% | 0.03% | -9.1% |
| Q4 2020 | $47,514,000 | +121.1% | 477,432 | +57.3% | 0.03% | -2.9% |
| Q3 2020 | $21,485,000 | +57.0% | 303,541 | +10.6% | 0.03% | +36.0% |
| Q2 2020 | $13,688,000 | – | 274,532 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |